According to experts, the risk of experiencing blood clots after getting the AstraZeneca vaccine is extremely rare, usually occurring within 42 days of vaccination. However, despite concerns raised by AstraZeneca’s admission that the vaccine could cause blood clots in rare instances, the Director of the Department of Health in Ho Chi Minh City, Tang Chi Thuong, has reassured the public that these side effects are very rare and can be effectively treated.
Thuong emphasized that blood clots are a potential side effect of Covid-19 vaccines and occur in various clinical situations, including Covid-19 infection. He urged people not to fear getting vaccinated as it is crucial in protecting against severe illness and death from Covid-19.
Doctor Truong Huu Khanh, Vice President of the Ho Chi Minh City Association of Infectious Diseases, echoed this sentiment and emphasized the importance of continued monitoring and early detection of potential complications following Covid-19 vaccination. The European Medicines Agency has also recommended the continued use of the AstraZeneca vaccine while stressing the need for consultation, detection, and treatment of possible complications that may arise.
In light of AstraZeneca’s acknowledgement of potential blood clotting side effects, experts believe that this recognition will guide future vaccine research and development, prompting closer attention to potential adverse effects in future vaccination efforts. Despite these concerns, health authorities continue to stress the importance of vaccination as a crucial tool in combating the Covid-19 pandemic.